Which regulators merit attention?
Prioritize transcription factors using target support, activity patterns, stability, and relevant prior evidence.
From regulatory hypotheses to research decisions
Identify candidate regulators, compare cell-state programs, and connect omics evidence to the next experiment. CD ComputaBio helps turn gene expression and supporting data into interpretable regulatory hypotheses.
Share your species, data type, study design, and research question for initial project feedback within 24 hours.
The essential answer
A gene regulatory network describes how regulators, such as transcription factors, influence gene expression. Computational GRN analysis infers candidate regulatory relationships from expression data and supporting evidence. These relationships generate testable hypotheses; they do not automatically establish direct binding or causality.
In a transcription-factor-centered network, nodes represent regulators and candidate target genes, while edges describe inferred or supported relationships. A regulon groups a regulator with its candidate targets. Its activity can summarize a regulatory program, but the meaning of each score depends on the inference and scoring method.
Our bioinformatics analysis services connect network construction with biological interpretation, reproducibility checks, and a clear next-step decision.
Want to investigate regulation in your own dataset? Send the species, data type, sample design, and research question for initial feedback within 24 hours. Assess my dataset →
Different networks, different conclusions
Genes can change together without directly regulating each other. Distinguishing association from a directional regulatory hypothesis is essential when interpreting network diagrams and selecting experiments.
| Network or Evidence | Main Question | Interpretation Boundary |
|---|---|---|
| Co-expression network | Which genes show coordinated expression across samples or cells? | Correlation does not identify a regulator, a direct interaction, or a causal direction. |
| Inferred regulatory network | Which regulators may be linked to which target genes in this context? | Direction and sign depend on the method; inferred edges remain hypotheses. |
| Experimentally supported relationship | Which candidate relationships have relevant binding or perturbation evidence? | Binding does not alone prove a functional effect, and evidence may be context-specific. |
Weighted co-expression modules can help organize expression patterns. They should not be relabeled as confirmed regulatory circuitry. Likewise, network centrality measures connectivity; it is not proof that a hub is a causal driver or a tractable drug target.
Not sure whether you need co-expression or regulatory network analysis? Share the data summary and the decision you want to make. Choose an analysis strategy →
Start with a decision
Prioritize transcription factors using target support, activity patterns, stability, and relevant prior evidence.
Compare regulatory activity across conditions or cell states while accounting for the biological replication structure.
Connect candidate target sets with pathways and phenotypes, distinguishing enrichment from a demonstrated mechanism.
Select focused regulator–target hypotheses for perturbation, binding, reporter, or phenotype experiments.
Data-matched inference
The analysis is selected around your study design, reference resources, and intended comparison. Human and mouse projects are common starting points; other species require an annotation and motif-resource review.
Use sample-level expression to study coordinated programs and candidate regulator relationships. Provide counts or abundance values with processing history, gene identifiers, group labels, and covariates.
Evaluate cell-type-associated regulons and activity patterns using annotated expression data, subject identifiers, and QC records. SCENIC-style approaches combine expression-based candidates with motif support. 1
Combine expression, chromatin accessibility, and motif information to investigate candidate TF–region–gene links. Jointly profiled RNA expression and chromatin accessibility data require different integration assumptions from separately generated datasets.
Use measured time points or controlled interventions to examine regulatory responses. Share the sampling schedule, treatment or perturbation, controls, and biological replicates.
Two downstream paths
A network can support different decisions. Biomarker studies ask whether a feature helps measure or predict a defined outcome. Target studies ask whether an intervention hypothesis merits functional testing. The evidence and validation requirements differ.
Biomarker pathway
Move from a regulatory feature to a defined context of use.
Regulon activity or network-derived features may provide candidate markers for disease classification, prognosis, or treatment response. Their value depends on reproducibility, the chosen endpoint, and performance beyond the data used to discover them.
Our biomarker discovery from omics data service extends candidate selection into endpoint-defined signature development and validation planning. When prediction is involved, feature selection and data-dependent network construction must be contained within training or resampling boundaries to avoid leakage.
Have expression data and phenotype labels? Share sample count, endpoint, covariates, and available validation cohorts for initial feedback within 24 hours. Discuss a network-guided biomarker study →
Target pathway
Move from a connected regulator to a testable intervention hypothesis.
Regulator candidates can be prioritized by state specificity, consistent target support, robustness, and existing functional evidence. High degree or differential expression alone does not establish therapeutic relevance.
Our target discovery from omics data service places network findings alongside disease relevance, complementary molecular layers, and available perturbation evidence. Causality, druggability, and safety require further assessment; they are not implied by a network rank.
Need to decide which regulators to test first? Share the disease model, comparison groups, candidate list, and functional evidence for initial feedback within 24 hours. Prioritize regulators for testing →
Traceable analysis
Specify biological context, comparison, endpoint, unit of replication, and the decision the network should support.
Review quality, identifiers, sample relationships, missingness, covariates, and confounding before selecting an inference strategy.
Harmonize gene IDs and relevant genome, motif, and prior-network resources; document exclusions and preprocessing.
Construct candidate relationships or regulons and estimate activity using methods appropriate to the available data.
Inspect resampling or repeated-run stability, threshold sensitivity, and relevant external evidence. Compare groups using the study design.
Explain candidate programs, summarize evidence, and define experiments that could discriminate between regulatory hypotheses.
Where applicable, comparisons report effect sizes, uncertainty, and multiplicity-adjusted significance. A larger number of cells cannot resolve a lack of donor-level replication, and an algorithm cannot reliably separate biology from a completely confounded batch design.
Beyond a network picture
QC findings, sample structure, exclusions, important covariates, and limits on the proposed inference.
Regulator, target, method-specific score, evidence source, context, and support annotations where available.
Candidate target sets and activity matrices, with definitions, scoring conventions, and interpretation notes.
Design-aware results for selected contrasts, including effect estimates and relevant uncertainty.
A focused shortlist explaining ranking components, biological context, disagreements, and proposed tests.
Readable local networks, summary plots, methods and version records, and an actionable validation strategy.
An edge should retain its context and evidence. The illustrative record below explains the fields; it is not a client result or a measured regulatory relationship.
| Regulator | Target | Score | Evidence Type | Context | Limitation |
|---|---|---|---|---|---|
| Candidate TF | Candidate gene | Method-specific importance | Expression inference + motif support | Defined cell type / condition | Direct regulation remains unconfirmed |
Published method evidence
SCENIC links expression-based candidate relationships with motif information, while SCENIC+ incorporates chromatin accessibility to infer enhancer-associated regulatory networks. 1, 2 These are method examples, not a fixed pipeline for every dataset. Figure 1 from the SCENIC+ study illustrates how expression, accessible regions, and motifs contribute different evidence.
This published figure explains a specific method and its evaluation. It does not establish the accuracy of a client network. For each project, we assess resource coverage, data compatibility, and whether the inferred relationships are stable enough to support the intended next step.
Label expression-based, motif-supported, binding-supported, and perturbation-supported relationships. Scores from different methods are not automatically comparable.
Check whether important candidates persist under reasonable analysis choices. A visually dense graph is not evidence of stronger biological support.
Match the experiment to the claim: binding assays for occupancy, perturbation for response, and functional assays for the phenotype of interest.
Practical project questions
There is no universal minimum. Feasibility depends on biological variability, the number of features, replication, data quality, and the intended comparison. Small datasets may support exploratory or prior-guided interpretation while limiting de novo inference and generalization.
A gene list can support enrichment or prior-network interpretation, but it does not contain the sample-level variation needed for expression-based network inference. Share the expression matrix and metadata if available; otherwise, the scope should explicitly reflect the missing information.
No. Edges depend on the inputs and model assumptions. Motif support can strengthen a regulatory hypothesis, but direct binding and functional consequences require relevant experiments.
Yes, after review. Counts, abundance matrices, AnnData/Seurat objects, and chromatin feature tables may be suitable. Provide processing history, species, reference versions, identifiers, sample or donor labels, and the biological comparison.
This page describes a custom analysis service. Public tools are cited to explain possible methods; the project is scoped around data review, analysis, interpretation, and agreed deliverables.
Dataset size, modalities, required preprocessing, species resources, contrasts, and robustness checks determine the scope. Initial feedback is provided within 24 hours; formal quotation and analysis timelines are confirmed after technical review.
Your next step
Send a brief summary of your species, tissue or cell system, data type, sample and donor counts, study groups, and intended outcome. We will provide initial feedback within 24 hours on the information available and the appropriate starting scope.
For files or a data-accession reference, email business@computabio.com. For confidential data, agree on transfer arrangements before sharing files. Detailed proposals and study execution have separate timelines.
Request a GRN Project ReviewSubmit your project details below, and our team will respond within 24 hours.
Talk to our technical team about your project!
I Want To Talk